Examining the reported rise in colorectal cancer among younger adults: A skeptical look at the evidence
By
surprisetalk
A baker's-dozen of insight crammed into one ring.
Summary
The article examines the reported rise in colorectal cancer (CRC) among young people, critically analyzing various proposed explanations including general health factors (obesity, insulin resistance, inflammation), ultra-processed foods and additives, and other environmental causes. The author takes a skeptical, nuanced approach ("Yes, but."), suggesting that while rates may be increasing, the explanations are complex and not fully understood.
Key quotes
· 3 pulledOver the past few years, I've seen many articles about mysterious rise in colorectal cancer (CRC) in young people.
Maybe modern people are unhealthy (obesity, low physical activity, diabetes, poor sleep), leading to insulin resistance and chronic inflammation
Maybe people are eating more ultra-processed foods that contain additives (like emulsifiers) that degra
You might also wanna read
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·2h ago
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·3h ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug works b
bit.ly·3h ago
Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study
This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu
pnas.org·3h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·4h ago
Personalized glioblastoma vaccine shows safety and survival promise in phase 1 trial
A phase 1 clinical trial at Siteman Cancer Center found that a personalized vaccine for glioblastoma, an aggressive brain cancer, is safe an
flip.it·4h ago